ONKI3 | Medical Subject Headings


Hierarchy:	Medical Subject Headings (MeSH) ∟ Biological Sciences ∟ Pharmacology ∟ Chemistry, Pharmaceutical ∟ Drug Design 16 coordinate concepts ∟ Biopharmaceutics \| ∟ Cytoprotection \| ∟ Depression, Chemical \| ∟ Dose-Response Relationship, Drug \| ∟ Down-Regulation \| ∟ Drug Interactions \| ∟ Drug Resistance \| ∟ Drug Tolerance \| ∟ Inhibitory Concentration 50 \| ∟ Kinetics \| ∟ Lethal Dose 50 \| ∟ Maximum Tolerated Dose \| ∟ No-Observed-Adverse-Effect Level \| ∟ Stimulation, Chemical \| ∟ Structure-Activity Relationship \| ∟ Up-Regulation Medical Subject Headings (MeSH) ∟ Chemical and Pharmacologic Phenomena ∟ Drug Design 16 coordinate concepts ∟ Biopharmaceutics \| ∟ Cytoprotection \| ∟ Depression, Chemical \| ∟ Dose-Response Relationship, Drug \| ∟ Down-Regulation \| ∟ Drug Interactions \| ∟ Drug Resistance \| ∟ Drug Tolerance \| ∟ Inhibitory Concentration 50 \| ∟ Kinetics \| ∟ Lethal Dose 50 \| ∟ Maximum Tolerated Dose \| ∟ No-Observed-Adverse-Effect Level \| ∟ Stimulation, Chemical \| ∟ Structure-Activity Relationship \| ∟ Up-Regulation Medical Subject Headings (MeSH) ∟ Health Occupations ∟ Pharmacology ∟ Chemistry, Pharmaceutical ∟ Drug Design 16 coordinate concepts ∟ Biopharmaceutics \| ∟ Cytoprotection \| ∟ Depression, Chemical \| ∟ Dose-Response Relationship, Drug \| ∟ Down-Regulation \| ∟ Drug Interactions \| ∟ Drug Resistance \| ∟ Drug Tolerance \| ∟ Inhibitory Concentration 50 \| ∟ Kinetics \| ∟ Lethal Dose 50 \| ∟ Maximum Tolerated Dose \| ∟ No-Observed-Adverse-Effect Level \| ∟ Stimulation, Chemical \| ∟ Structure-Activity Relationship \| ∟ Up-Regulation Medical Subject Headings (MeSH) ∟ Natural Sciences ∟ Chemistry ∟ Chemistry, Pharmaceutical ∟ Drug Design 16 coordinate concepts ∟ Biopharmaceutics \| ∟ Cytoprotection \| ∟ Depression, Chemical \| ∟ Dose-Response Relationship, Drug \| ∟ Down-Regulation \| ∟ Drug Interactions \| ∟ Drug Resistance \| ∟ Drug Tolerance \| ∟ Inhibitory Concentration 50 \| ∟ Kinetics \| ∟ Lethal Dose 50 \| ∟ Maximum Tolerated Dose \| ∟ No-Observed-Adverse-Effect Level \| ∟ Stimulation, Chemical \| ∟ Structure-Activity Relationship \| ∟ Up-Regulation X
Broader terms:	Medical Subject Headings (MeSH) ∟ Biological Sciences ∟ Pharmacology ∟ Chemistry, Pharmaceutical ∟ Drug Design Medical Subject Headings (MeSH) ∟ Chemical and Pharmacologic Phenomena ∟ Drug Design Medical Subject Headings (MeSH) ∟ Health Occupations ∟ Pharmacology ∟ Chemistry, Pharmaceutical ∟ Drug Design Medical Subject Headings (MeSH) ∟ Natural Sciences ∟ Chemistry ∟ Chemistry, Pharmaceutical ∟ Drug Design Chemistry, Pharmaceutical > Pharmacology > Biological Sciences > Medical Subject Headings (MeSH) Chemical and Pharmacologic Phenomena > Medical Subject Headings (MeSH) Chemistry, Pharmaceutical > Pharmacology > Health Occupations > Medical Subject Headings (MeSH) Chemistry, Pharmaceutical > Chemistry > Natural Sciences > Medical Subject Headings (MeSH) X
Annotation:	no qualif; do not confuse with DESIGNER DRUGS X
History note:	Chemistry, Pharmaceutical (1966-1988) \| Drugs (1966-1988)X
historyNote*:	89 X
publicMeSHNote*:	89 X
Scope note:	The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include pharmacokinetics, dosage analysis, or drug administration analysis. X
activeMeSHYear*:	2007X
dateCreated*:	1988-04-21X
dateEstablished*:	1989-01-01X
dateRevised*:	2006-07-05X
recordAuthorizer*:	sjnX
recordMaintainer*:	ssbX
recordOriginator*:	EJBX
Related term:	Designer Drugs X
Type:	Concept X
Coordinate terms:	Biopharmaceutics \| Cytoprotection \| Depression, Chemical \| Dose-Response Relationship, Drug \| Down-Regulation \| Drug Interactions \| Drug Resistance \| Drug Tolerance \| Inhibitory Concentration 50 \| Kinetics \| Lethal Dose 50 \| Maximum Tolerated Dose \| No-Observed-Adverse-Effect Level \| Stimulation, Chemical \| Structure-Activity Relationship \| Up-Regulation X
URI:	X
Labels and equivalent concepts:	Lääkesuunnittelu (fi) Lääkkeiden kehittely (fi, replaced) Lääkkeiden suunnittelu (fi, replaced) Lääkkeen suunnittelu (fi, replaced) Lääketutkimus (fi, replaced) Lääkekehittely (fi, replaced) Lääkeen kehittely (fi, replaced) Läkemedelsdesign (sv) X
Share:	X